2019
DOI: 10.1089/cbr.2018.2698
|View full text |Cite
|
Sign up to set email alerts
|

LncRNA KB-1471A8.2 Overexpression Suppresses Cell Proliferation and Migration and Antagonizes the Paclitaxel Resistance of Ovarian Cancer Cells

Abstract: Objective: The aim was to investigate the lncRNA KB-1471A8.2 function in ovarian cancer progression and paclitaxel resistance. Methods: The expression and distribution of KB-1471A8.2 was detected by qRT-PCR. The cell proliferation, apoptosis, invasion, migration and chemoresistance were analyzed by CCK8 assay, flow cytometry and transwell assay. The expression of DEPTOR, whose sequence is reverse overlapped with KB-1471A8.2 was analyzed by qRT-PCR, western blot and immunofluorescence. The cell cycle and the ce… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
11
0

Year Published

2020
2020
2022
2022

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 16 publications
(11 citation statements)
references
References 30 publications
0
11
0
Order By: Relevance
“…In addition, the overexpression of lncRNA-FER1L4 could increase the sensitivity of ovarian cancer cells to paclitaxel by inhibiting the MAPK signaling pathway [25]. Also, lncRNA-KB-1471A8.2 was reported to be downregulated in ovarian cancer tissues and chemoresistant ovarian cancer cells and acted as tumor suppressor gene by inhibiting the expression of CDK4 [26].…”
Section: Discussionmentioning
confidence: 99%
“…In addition, the overexpression of lncRNA-FER1L4 could increase the sensitivity of ovarian cancer cells to paclitaxel by inhibiting the MAPK signaling pathway [25]. Also, lncRNA-KB-1471A8.2 was reported to be downregulated in ovarian cancer tissues and chemoresistant ovarian cancer cells and acted as tumor suppressor gene by inhibiting the expression of CDK4 [26].…”
Section: Discussionmentioning
confidence: 99%
“…In addition, researchers found over-expression of lncRNA-FER1L4 could increase the sensitivity of ovarian cancer cells to paclitaxel by inhibiting MAPK signaling pathways [25]. Also, lncRNA-KB-1471A8.2 was reported to be down-regulated in ovarian cancer tissues and chemo-resistant ovarian cancer cells and could act as tumor-suppressor gene by inhibiting the expression of CDK4 [26].…”
Section: Discussionmentioning
confidence: 99%
“…In addition, the overexpression of lncRNA-FER1L4 could increase the sensitivity of ovarian cancer cells to paclitaxel by inhibiting the MAPK signaling pathway [ 26 ]. Also, lncRNA-KB-1471A8.2 was reported to be downregulated in ovarian cancer tissues and chemoresistant ovarian cancer cells and acted as tumor suppressor gene by inhibiting the expression of CDK4 [ 27 ].…”
Section: Discussionmentioning
confidence: 99%